Monday, November 6, 2017
- 9:00AM-11:00AM
-
Abstract Number: 1588
“Neoplasia in Patients with Systemic LUPUS Erythematosus in Spain: Relesser Registry DATA”
Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster II: Damage and Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 1614
“Do You Know What I Mean?” a Tool to Understand What Lupus Patients Comprehend
Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster II: Damage and Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 1753
“Recurrent Venous Thromboembolic Events in Granulomatosis with Polyangiitis Patients”
Vasculitis Poster II: ANCA-Associated Vasculitis- 9:00AM-11:00AM
-
Abstract Number: 1275
101 Juvenile Myositis Patients Characterized By Myositis Specific Antibodies: Disease Activity and Damage over 60 Months
Pediatric Rheumatology – Clinical and Therapeutic Aspects Poster II: Lupus and Related Disorders, Myositis, Scleroderma and Vasculitis- 9:00AM-11:00AM
-
Abstract Number: 1355
14-3-3η: Useful for More Than the Diagnosis of Rheumatoid Arthritis?
Rheumatoid Arthritis – Clinical Aspects Poster II: Pathophysiology, Autoantibodies, and Disease Activity Measures- 9:00AM-11:00AM
-
Abstract Number: 1643
15 Year Comparative Analysis of Cardiovascular Events in Female Subjects with Lupus Versus Controls
Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster II: Damage and Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 1699
A 10-Year National Trend in Acute Coronary Syndrome Among Hospitalized Patients with Systemic Sclerosis
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster II- 9:00AM-11:00AM
-
Abstract Number: 1142
A Case Control Study of Anakinra Use for Acute Gout in a VA Patient Cohort Reveals Association with East Asian Descent, High Urate Burden, and Increased Co-Morbidities and All-Cause Mortality
Metabolic and Crystal Arthropathies Poster I- 9:00AM-11:00AM
-
Abstract Number: 1134
A Case Series of Gout and Downs Syndrome – a New Paradigm for Detecting Disease Associations Using Big Data
Metabolic and Crystal Arthropathies Poster I- 9:00AM-11:00AM
-
Abstract Number: 1055
A Combination of Self-Reported Symptoms and ACPA Testing Can Identify Individuals with Previously Undiagnosed Inflammatory Arthritis in a Health-Fair Setting
Health Services Research Poster II: Osteoarthritis and Rheumatoid Arthritis- 9:00AM-11:00AM
-
Abstract Number: 959
A Disintegrin and Metalloprotease -17 Is Overexpressed on Rheumatoid Arthritis Osteoblasts and Is Regulated with TNF-α Stimulation
Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis Poster II: Mesenchymal Cells Do React - But How?- 9:00AM-11:00AM
-
Abstract Number: 957
A Disintegrin and Metalloprotease 15 Is Expressed on Rheumatoid Arthritis Synovial Tissue Endothelial Cells and Mediates Angiogenesis
Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis Poster II: Mesenchymal Cells Do React - But How?- 9:00AM-11:00AM
-
Abstract Number: 1703
A Double-Blind, Randomized, Placebo-Controlled, Dose-Escalation, Multi-Center Study of a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells in Patients with Rheumatoid Arthritis and Incomplete Response to at Least One Tnfα Inhibitor
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster II